These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 12583274)
1. [The study about the source, harmfulness and preventive measures of indissoluble particles in injection]. Tang LM Zhongguo Yi Liao Qi Xie Za Zhi; 2001 Nov; 25(6):359-61. PubMed ID: 12583274 [TBL] [Abstract][Full Text] [Related]
2. Minimizing human intervention in intravenous admixture practice. Tribble DA Am J Health Syst Pharm; 2010 Mar; 67(5):389-90. PubMed ID: 20172990 [No Abstract] [Full Text] [Related]
3. Overview of the forthcoming PDA task force report on the inspection for visible particles in parenteral products: practical answers for present problems. Knapp JZ PDA J Pharm Sci Technol; 2003; 57(2):131-9. PubMed ID: 14674515 [No Abstract] [Full Text] [Related]
4. Leaching of diethylhexyl phthalate from polyvinyl chloride materials into etoposide intravenous solutions. de Lemos ML; Hamata L; Vu T J Oncol Pharm Pract; 2005 Dec; 11(4):155-7. PubMed ID: 16595068 [TBL] [Abstract][Full Text] [Related]
6. [ON TESTS FOR PYROGENIC CONTAMINATION. 2. A REPORT ON DISCOVERIES FROM TESTS ON INJECTION AND INFUSION SOLUTIONS FROM PHARMACIES AND HOSPITALS]. DRESSEL H Pharm Prax; 1964; 10():225-8. PubMed ID: 14323875 [No Abstract] [Full Text] [Related]
7. LETTER: Safety of various intravenous solution systems. Wood WA Am J Hosp Pharm; 1975 Apr; 32(4):359. PubMed ID: 1130406 [No Abstract] [Full Text] [Related]
8. Study on the thermal stability of green fluorescent protein (GFP) in glucose parenteral formulations. Ishii M; Kunimura JS; Penna TC; Cholewa O Int J Pharm; 2007 Jun; 337(1-2):109-17. PubMed ID: 17275229 [TBL] [Abstract][Full Text] [Related]
9. [Control of foreign particle contamination of injectable solutions]. Van Ooteghem M; Moës A J Pharm Belg; 1972; 27(4):493-504. PubMed ID: 4681079 [No Abstract] [Full Text] [Related]
10. [Effect of gum on injection solutions. Foreign particles]. van Damme PA Pharm Acta Helv; 1970 Sep; 45(9):564-71. PubMed ID: 5469386 [No Abstract] [Full Text] [Related]
11. [Control for the absence of mechanical particles in injection solutions]. Beskrovnyi RP Farmatsiia; 1971; 20(2):59-61. PubMed ID: 5562916 [No Abstract] [Full Text] [Related]
12. The effect of alcohol swabs and filter straws on reducing contamination of glass ampoules used for neuroaxial injections. Hemingway CJ; Malhotra S; Almeida M; Azadian B; Yentis SM Anaesthesia; 2007 Mar; 62(3):286-8. PubMed ID: 17300308 [TBL] [Abstract][Full Text] [Related]
13. [Formulation and stability study of sucred solutions for a clinical trial in neonates]. Senis-Loiseau C; Vaillant C; Markiewicz-Massy A; Torck M; Thielmans B Ann Pharm Fr; 2003 Nov; 61(6):425-30. PubMed ID: 14639195 [TBL] [Abstract][Full Text] [Related]
14. Stability of doripenem in vitro in representative infusion solutions and infusion bags. Psathas PA; Kuzmission A; Ikeda K; Yasuo S Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795 [TBL] [Abstract][Full Text] [Related]
15. Letter: Harmful effects of particles in intravenous infusions. Myers JA Am J Hosp Pharm; 1975 Jan; 32(1):11. PubMed ID: 1124773 [No Abstract] [Full Text] [Related]
16. Microbial growth tests in anti-neoplastic injectable solutions. Paris I; Paci A; Rey JB; Bourget P J Oncol Pharm Pract; 2005 Mar; 11(1):7-12. PubMed ID: 16460598 [TBL] [Abstract][Full Text] [Related]
17. Transfer of soil contaminants to home-produced eggs and preventive measures to reduce contamination. Waegeneers N; De Steur H; De Temmerman L; Van Steenwinkel S; Gellynck X; Viaene J Sci Total Environ; 2009 Jul; 407(15):4438-46. PubMed ID: 19162298 [TBL] [Abstract][Full Text] [Related]